Linnea®
Butylscopolamine

 

PLANT

Duboisia

PART OF THE PLANT USED

Leaves

APPEARANCE

White or almost white Crystalline powder

CAS NUMBER

149-64-4


Butylscopolamine is a peripherally-acting antimuscarinic and anticholinergic agent commonly used for its antispasmodic properties

We have been producing our semi-synthetic, pharmaceutical-grade Butylscopolamine since 1985, obtaining it from the leaves of the Duboisia plant sourced from our own cultivation site in Australia


Products

Semi-synthetic powder
Purity grade 98.0%÷101.0%


Pharmaceutical Uses

  • Smooth-muscles relaxation
  • Dysmenorrhoea
  • Renal colic pain
  • Irritable bowel syndrome

Key Insights

  • Vertically integrated manufacturing
  • Complies with Ph. Eur. “Hyoscine butylbromide” monograph, current edition
  • Linnea is the official supplier to EDQM for Ph. Eur. Analytical Standard for Hyoscine butylbromide for system suitability CRS
The logo indicates that, while producing butylscopolamine, Linnea’s facility remains GMP certified. GMP stands for Good Manufacturing Practices.
The logo indicates that Linnea’s raw material for butylscopolamine is GACP compliant. GACP stands for Good Agricultural Collection Practices.

GACP compliant

The logo indicates that Linnea is CEP certified for producing butylscopolamine. CEP stands for Certificate of Suitability.
The logo indicates that Linnea Natural Pharma Solutions has created a DMF for producing butylscopolamine. DMF stands for Drug Master Files which details information about the manufacturing processes of Linnea.
The logo indicates that Linnea is compliant with the European Pharmacopoeia standards for producing butylscopolamine ingredients.
Linnea® Australian cultivations of Duboisia

Linnea® Australian cultivations of Duboisia


LINNEA® PLANTATIONS
From Leaf to Care

Linnea’s Butylscopolamine is sourced from our own Duboisia cultivations in Australia

Duboisia is native to Australia and a few other regions, thriving in the country’s dry, harsh conditions. Most of Linnea’s Butylscopolamine is derived from its Duboisia cultivations in Australia, where the alkaloid-rich leaves are meticulously harvested to take full advantage of the optimal climatic conditions, ensuring the highest concentration of the active ingredient.

Proudly vertically integrated, we manage the entire supply chain for this valuable ingredient. Since 1985, we have been manufacturing Butylscopolamine in our GMP-certified facility in Switzerland, ensuring full traceability throughout the process.

GACP COMPLIANT
GMP CERTIFIED SITE

More on our APPROACH

Education, Community and Thought Leadership


Linnea goes beyond manufacturing to support our customers, connect with the community, and educate worldwide about the potential therapeutic benefits of our ingredients

Get the latest
Linnea® news